Sarcopenia: Age-related skeletal muscle changes from determinants to physical disability

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 4, 2006, Pages 703-719

  Di Iorio, Angelo ^a   Abate, M ^a   Di Renzo, D ^a   Russolillo, A ^a   Battaglini, C ^a   Ripari, P ^a   Saggini, R ^a   Paganelli, R ^a   Abate, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Elderly; Inflammation; Sarcopenia; Signaling pathways

Indexed keywords

ANABOLIC AGENT; CORTICOSTEROID; CYTOKINE; GROWTH HORMONE; HYDROCORTISONE; LEPTIN; MUSCLE PROTEIN; OXYGEN RADICAL; PLACEBO; PRASTERONE SULFATE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

AGING; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DETOXIFICATION; DIET SUPPLEMENTATION; DRUG MECHANISM; EPIGENETICS; EXERCISE; GENETIC ANALYSIS; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; IMMOBILIZATION; INFLAMMATION; LIFESPAN; LIFESTYLE MODIFICATION; MALNUTRITION; META ANALYSIS; MUSCLE ATROPHY; MUSCLE FORCE; MUSCLE HYPERTROPHY; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; TRAINING;

EID: 33846409030     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900401     Document Type: Review

References (64)

1. Lexell J., C.C. Taylor and M. Sjostrom. 1988. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci. 84:275.
2. Janssen I. 2006. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J. Am. Geriatr. Soc. 54:56.
3. Janssen I., S.B. Heymsfield and R. Ross. 2002. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 50:889.
4. Baumgartner R.N., K.M. Koehler, D. Gallagher, L. Romero, S.B. Heymsfield, R.R. Ross, P.J. Garry and R.D. Lindeman. 1998. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 147:755.
5. Zoico E., V. Di Francesco, J.M. Guralnik, G. Mazzali, A. Bortolani, S. Guariento, G. Sergi, O. Bosello and M. Zamboni. 2004. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int. J. Obes. Relat. Metab. Disord. 28:234.
6. Iannuzzi-Sucich M., K.M. Prestwood and A.M. Kenny. 2002. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J. Gerontol. A. Biol. Sci. Med. Sci. 57:772.
7. Newman A.B., V. Kupelian, M. Visser, E. Simonsick, B. Goodpaster, M. Nevitt, S.B. Kritchevsky, F.A. Tylavsky, S.M. Rubin and T.B. Harris. 2003. Sarcopenia: alternative definitions and associations with lower extremity function. J. Am. Geriatr. Soc. 51:1602.
8. Roubenoff R. 2003. Sarcopenia: effects on body composition and function. J. Gerontol. A Biol. Sci. Med Sci. 58:1012.
9. Castaneda C., P.L. Gordon, K.L. Uhlin, A.S. Levey, J.J. Kehayias, J.T. Dwyer, R.A. Fielding, R. Roubenoff and M.F. Singh. 2001. Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency. A randomized, controlled trial. Ann. Intern. Med. 135:965.
10. McKoy G., W. Ashley, J. Mander, S.Y. Yang, N. Williams, B. Russell and G. Goldspink. 1999. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J. Physiol. 516:583.
11. Hameed M., R.W. Orrell, M. Cobbold, G. Goldspink and S.D. Harridge. 2003. Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J. Physiol. 547:247.
12. Glass D.J. 2005. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell. Biol 37:1974.
13. Wullschleger S., R. Loewith and M.N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124:471.
14. Edstrom E., M. Altun, M. Hagglund and B. Ulfhake. 2006. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J. Gerontol. A Biol. Sci. Med Sci. 61:663.
15. Nader G.A. 2005. Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int. J. Biochem. Cell. Biol. 37:1985.
16. Latres E., A.R. Amini, A.A. Amini, J. Griffiths, F.J. Martin, Y. Wei, H.C. Lin, G.D. Yancopoulos and D.J. Glass. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J. Biol Chem. 280:2737.
17. Spencer J.A., S. Eliazer, R.L. Ilaria Jr., J.A. Richardson and E.N. Olson. 2000. Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J. Cell Biol. 150:771.
18. McElhinny A.S., K. Kakinuma, H. Sorimachi, S. Labeit and C.C. Gregorio. 2002. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J. Cell Biol. 157:125.
19. Gregorio C.C., C.N. Perry and A.S. McElhinny. 2005. Functional properties of the titin/connectin-associated proteins, the muscle-specific RING finger proteins (MURFs), in striated muscle. J. Muscle Res. Cell Motil. 26:389.
20. Lecker S.H., R.T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, J. Bailey, S.R. Price, W.E. Mitch and A.L. Goldberg. 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 18:39.
21. Kandarian S.C. and R.W. Jackman. 2006. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33:155.
22. Tawa N.E. Jr., R. Odessey and A.L. Goldberg. 1997. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100:197.
23. Goldberg A.L. 2003. Protein degradation and protection against misfolded or damaged proteins. Nature 426:895.
24. Acharyya S., K.J. Ladner, L.L. Nelsen, J. Damrauer, P.J. Reiser, S. Swoap and D.C. Guttridge. 2004. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Invest. 114:370.
25. Di Iorio A., L. Ferrucci, E. Sparvieri, A. Cherubini, S. Volpato, A. Corsi, M. Bonafe, C. Franceschi, G. Abate and R. Paganelli. 2003. Serum IL-1beta levels in health and disease: a population-based study. 'The In CHIANTI study'. Cytokine 22:198.
26. Morley J.E. and R.N. Baumgartner. 2004. Cytokine-related aging process. J. Gerontol. A Biol. Sci. Med. Sci. 59:924.
27. Roth S.M., M.A. Schrager, R.E. Ferrell, S.E. Riechman, E.J. Metter, N.A. Lynch, R.S. Lindle and B.F. Hurley. 2001. CNTF genotype is associated with muscular strength and quality in humans across the adult age span. J. Appl Physiol 90:1205.
28. Visser M., M. Pahor, D.R. Taaffe, B.H. Goodpaster, E.M. Simonsick, A.B. Newman, M. Nevitt and T.B. Harris. 2002. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol Sci. Med Sci. 57:326.
29. Ferrucci L., B.W. Penninx, S. Volpato, T.B. Harris, K. Bandeen-Roche, J. Balfour, S.G. Leveille, L.P. Fried and J.M. Md. 2002. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J. Am. Geriatr. Soc. 50:1947.
30. Pollack M. and C. Leeuwenburgh. 2001. Apoptosis and aging: role of the mitochondria. J. Gerontol. A Biol. Sci. Med Sci. 56:475.
31. Grune T., R. Shringarpure, N. Sitte and K. Davies. 2001. Age-related changes in protein oxidation and proteolysis in mammalian cells. J. Gerontol. A Biol. Sci. Med Sci. 56:459.
32. Vandervoort A.A. 2002. Aging of the human neuromuscular system. Muscle Nerve 25:17.
33. Lauretani F., S. Bandinelli, B. Bartali, A. Di Iorio, V. Giacomini, A.M. Corsi, J.M. Guralnik and L. Ferrucci. 2006. Axonal degeneration affects muscle density in older men and women. Neurobiol. Aging 27:1145.
34. Melzer W. 2006. When sparks get old. J. Cell Biol. 174:613.
35. Wagers A.J. and I.M. Conboy. 2005. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122:659.
36. Goldspink G. and S.D. Harridge. 2004. Growth factors and muscle ageing. Exp. Gerontol. 39:1433.
37. McPherron A.C., A.M. Lawler and S.J. Lee. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83.
38. Conboy I.M. and T.A. Rando. 2005. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle 4:407.
39. Conboy I.M., M.J. Conboy, G.M. Smythe and T.A. Rando. 2003. Notch-mediated restoration of regenerative potential to aged muscle. Science 302:1575,
40. Vermeulen A. and J.M. Kaufman. 2002. Diagnosis of hypogonadism in the aging male. Aging Male 5:170.
41. Araujo A.B., A.B. O'Donnell, D.J. Brambilla, W.B. Simpson, C. Longcope, A.M. Matsumoto and J.B. McKinlay. 2004. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study J. Clin. Endocrinol Metab. 89:5920.
42. Paganelli R., A. Di Iorio, A. Cherubini, F. Lauretani, C. Mussi, S. Volpato, M. Abate, G. Abate and L. Ferrucci. 2006. Frailty of older age: the role of the endocrine - immune interaction. Current Pharmaceutical Design 12:3417.
43. Kotler D.P. 2000. Cachexia. Ann. Intern. Med 133:622.
44. Bauer M.E. 2005. Stress, glucocorticoids and ageing of the immune system. Stress 8:69.
45. Fisher A.L. 2004. Of worms and women: sarcopenia and its role in disability and mortality. J. Am. Geriatr. Soc. 52:1185.
46. Chien K.R. and G. Karsenty. 2005. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle and bone. Cell 120:533.
47. Barton-Davis E.R., D.I. Shoturma, A. Musaro, N. Rosenthal and H.L. Sweeney. 1998. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl. Acad. Sci USA 95:15603.
48. Snyder P.J., H. Peachey, P. Hannoush, J.A. Berlin, L. Loh, D.A. Lenrow, J.H. Holmes, A. Dlewati, J. Santanna, C.J. Rosen and B.L. Strom. 1999. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J. Clin. Endocrinol. Metab. 84:2647.
49. Lee S.J. 2004. Regulation of muscle mass by myostatin. Annu. Rev. Cell Dev. Biol. 20:61.
50. Guarente L. and F. Picard. 2005. Calorie restriction-the SIR2 connection. Cell 120:473.
51. Baumgartner R.N., S.J. Wayne, D.L. Waters, I. Janssen, D. Gallagher and J.E. Morley. 2004. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12:1995.
52. Villareal D.T., M. Banks, C. Siener, D.R. Sinacore and S. Klein. 2004. Physical frailty and body composition in obese elderly men and women. Obes. Res. 12:913.
53. Fried L.P. and J.M. Guralnik. 1997. Disability in older adults: evidence regarding significance, etiology and risk. J. Am. Geriatr. Soc. 45:92.
54. Fried L.P., K. Bandeen-Roche, J.D. Kasper and J.M. Guralnik. 1999. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J. Clin. Epidemiol. 52:27.
55. Visser M., S.M. Pluijm, V.S. Stel, R.J. Bosscher and D.J. Deeg. 2002. Physical activity as a determinant of change in mobility performance: the Longitudinal Aging Study Amsterdam. J. Am. Geriatr. Soc. 50:1774.
56. Landi F., M. Cesari, G. Onder, F. Lattanzio, E.M. Gravina and R. Bernabei. 2004. Physical activity and mortality in frail, community-living elderly patients. J. Gerontol. A Biol. Sci. Med. Sci. 59:833.
57. Klitgaard H., M. Mantoni, S. Schiaffino, S. Ausoni, L. Gorza, C. Laurent-Winter, P. Schnohr and B. Saltin. 1990. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol. Scand. 140:41.
58. Mitnitski A., X. Song, I. Skoog, G. Broe, J.L. Cox, E. Grunfeld and K. Rockwood. 2005. Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J. Am. Geriatr. Soc. 53:2184.
59. Binder E.F., K.E. Yarasheski, K. Steger-May, D.R. Sinacore, M. Brown, K.B. Schechtman and J.O. Holloszy. 2005. Effects of progressive resistance training on body composition in frail older adults: results of a randomized, controlled trial. J. Gerontol. A Biol. Sci. Med Sci. 60:1425.
60. Latham N.K., D.A. Bennett, C.M. Stretton and C.S. Anderson. 2004. Systematic review of progressive resistance strength training in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 59:48.
61. Yarasheski K.E. 2003. Exercise, aging and muscle protein metabolism. J. Gerontol. A Biol. Sci. Med. Sci. 58:918.
62. Fiatarone Singh M.A. 2002. Exercise in the oldest old: some new insights and unanswered questions. J. Am. Geriatr. Soc. 50:2089.
63. Meredith C.N., M.J. Zackin, W.R. Frontera and W.J. Evans. 1989. Dietary protein requirements and body protein metabolism in endurance-trained men. J. Appl Physiol. 66:2850.
64. Blackman M.R., J.D. Sorkin, T. Munzer, M.F. Bellantoni, J. Busby-Whitehead, T.E. Stevens, J. Jayme, K.G. O'Connor, C. Christmas, J.D. Tobin, K.J. Stewart, E. Cottrell, C. St Clair, K.M. Pabst and S.M. Harman. 2002. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 288:2282.